Article
A biomarker-driven therapy for ovarian cancer
Rating:
0.0
Views:
76
Likes:
1
Library:
1
An antibody–drug conjugate showed impressive anti-cancer activity in selected patients with platinum-resistant ovarian cancer, and could become a new standard of care.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value